| Absztrakt az értekezés nyelvén | Schizophrenia, a severe and disabling brain disorder, is affecting 0,85% (0,4–1,4%) of the
general population. It is frequently a life-long and deteriorating disorder. Schizophrenia begins in
early adulthood, and the disorder usually disrupts the way of life. Beside the clinical symptoms
of schizophrenia social dysfunction is the trademark of schizophrenia and a major burden on the
individual and on their families. While a great body of literature deals with the deficits of social
functioning in schizophrenia, still only a few, if any, assessment tools can detect the deficits
accurately in spite of the certainty of the presence of the diversified impairments.
Although antipsychotics brought a breakthrough in the treatment of schizophrenia, a significant
amount of evidence confirmed that best results can be achieved with the combination of drug
treatment and psychosocial interventions. Implementing evidence-based psychosocial
interventions to everyday clinical practice, however, is rather slow usually due to lack of
different types of resources (Drake et al., 2009). These facts emphasize the necessity of new
ways in research approaches promising easily implementable opportunities to measure and treat
social impairments. |
